Bioavailability is defined as:

Bioavailability is defined as:

• A. The rate and extent to which the active ingredient is absorbed and becomes available at the site of action.
• B. The time to peak concentration after dosing.
• C. The maximum concentration achieved in plasma.
• D. Measured by the amount of drug in the plasma.

Answer: (A)

Bioavailability describes how much of the administered drug reaches the systemic circulation and is available at the site of action, reflecting both how much is absorbed (extent) and how quickly it becomes available (rate). This makes the definition that emphasizes the rate and extent of absorption and the drug being available at the action site the best fit. Other statements describe related pharmacokinetic ideas: the time to peak concentration is about how fast you reach the maximum plasma level, the maximum concentration is the peak level itself, and simply measuring drug in plasma doesn’t capture the fraction that actually becomes available at the site of action.

Bioavailability describes how much of the administered drug reaches the systemic circulation and is available at the site of action, reflecting both how much is absorbed (extent) and how quickly it becomes available (rate). This makes the definition that emphasizes the rate and extent of absorption and the drug being available at the action site the best fit.

Other statements describe related pharmacokinetic ideas: the time to peak concentration is about how fast you reach the maximum plasma level, the maximum concentration is the peak level itself, and simply measuring drug in plasma doesn’t capture the fraction that actually becomes available at the site of action.